Status:

COMPLETED

Spinal Cord Stimulation in the Treatment of Chronic, Intractable Pain Using the Nalu™ Neurostimulation System

Lead Sponsor:

Nalu Medical, Inc.

Conditions:

Pain, Chronic

Pain, Intractable

Eligibility:

All Genders

21-80 years

Phase:

NA

Brief Summary

The Nalu Neurostimulation System is capable of delivering multiple therapy options to address patient needs. The study will confirm the efficacy, safety, comfort and compliance with the Nalu Neurostim...

Detailed Description

The study is a prospective, multi-center, open-label, single-arm clinical study with each subject serving as their own control. The study will confirm device efficacy, safety, comfort and compliance w...

Eligibility Criteria

Inclusion

  • Subject is between 21 and 80 years of age at enrollment.
  • Subject has chronic (defined as at least 6 months duration), intractable neuropathic pain of legs and/or back; any nociceptive pain must be less prominent than the neuropathic pain.
  • Subject's pain is unresponsive to conservative treatment options.
  • Subject has a VAS Score of at least 6 in the back and/or leg at screening.

Exclusion

  • Subject currently has an active implantable medical device such as a drug pump, spinal cord stimulator, sacral nerve stimulator, deep brain stimulator, and/or cardiac pacemaker.
  • Subject has previously failed SCS therapy (either trial system evaluation or permanent implant).
  • Subject has had an ablative procedure directed at the spinal cord including the dorsal root entry zone (DREZ) or dorsal root ganglion (DRG).
  • Subject has pain in another anatomic region besides the leg(s) and back that would interfere with their ability to accurately report pain (e.g. hip joint pain).
  • Subject has a medical condition that would prevent them from participating in the current study per investigator's or medical monitor's judgment.

Key Trial Info

Start Date :

July 16 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 13 2022

Estimated Enrollment :

110 Patients enrolled

Trial Details

Trial ID

NCT04503109

Start Date

July 16 2020

End Date

September 13 2022

Last Update

February 15 2023

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

CA Ortho and Spine

Larkspur, California, United States, 94939

2

IPM Medical Group, Inc.

Walnut Creek, California, United States, 94598

3

International Spine, Pain and Performance Center

Washington D.C., District of Columbia, United States, 20006

4

The Orthopaedic Institute

Gainesville, Florida, United States, 32607